Figure 7.

Hydrophilic profile of the mouse VH62, amino acid residues 80–125, engineered with the 93ASSDSSNTE101 peptide of the rat Vβ8.2 TCR-CDR3.

Musselli et al. Journal of Immune Based Therapies and Vaccines 2004 2:9   doi:10.1186/1476-8518-2-9
Download authors' original image